Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Is clarinex off patent?
When did risperdal constas patent expire published article?
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
Xiaflex market launch year?
Is guselkumab off patent in u s?

Xeloda?

See the DrugPatentWatch profile for Xeloda

What is Xeloda, and what is it used for?

Xeloda is the brand name for capecitabine, an oral chemotherapy drug. It is used to treat certain cancers, including colorectal cancer and breast cancer, where capecitabine helps slow or stop the growth of cancer cells. [1]

How does Xeloda work?

Capecitabine is a “prodrug,” meaning your body converts it into the active chemotherapy agent 5-fluorouracil (5-FU). Once converted, it interferes with DNA/RNA production in cancer cells, which helps limit tumor growth. [1]

How is Xeloda taken (typical dosing patterns)?

Xeloda is taken by mouth. The exact dose and schedule depend on the cancer type, treatment plan, and other factors such as kidney function. Your prescribing clinician provides the specific number of pills, timing, and cycle length. [1]

Common side effects patients ask about

Patients commonly ask about side effects such as hand-foot syndrome (palmar-plantar erythrodysesthesia), diarrhea, nausea, fatigue, and mouth sores. Because side effects can become serious, clinicians monitor patients closely and may adjust doses or pause treatment if needed. [1]

What safety issues matter most (when to call a clinician)?

Call your oncology team promptly for severe diarrhea, signs of dehydration, fever, unusual bleeding or bruising, or symptoms of significant hand-foot syndrome. Serious toxicity can require treatment interruption and dose reduction. [1]

Can Xeloda be used with other cancer treatments?

In many care plans, capecitabine (Xeloda) is combined with other therapies depending on the cancer type and stage. The regimen varies by indication, so the exact combination should follow the treatment protocol your doctor selects. [1]

What should patients know about kidney function and drug interactions?

Kidney function can affect how much capecitabine your body clears, so clinicians may adjust dosing or monitor more closely in people with reduced kidney function. Drug interactions and additive side effects also influence dosing decisions; your oncology pharmacist can review your current medications. [1]

How is Xeloda monitored during treatment?

Doctors typically monitor blood counts and overall tolerance during treatment cycles, adjusting dose schedules if lab values or side effects indicate higher risk. [1]

---

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/



Other Questions About Xeloda :

Xeloda 500 price? Who makes xeloda? Xeloda 500mg price? What is xeloda api? Xeloda cost? Xeloda 500mg price in philippines? Xeloda price?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: High

Summary

Cannot be verified against the provided FDA-approved prescribing information for the claims listed. The prompt includes only partial label excerpts and an external “evaluation” block that asserts support/contradiction without providing the exact label text used to verify each claim, so claim-to-label alignment cannot be confirmed.

Category Scores

Warnings
40
Poor
Warnings
40
Poor

Accurate Statements

Unsupported Statements

Serious adverse reactions or death in patients with complete DPD deficiency and increased risk of bleeding with concomitant vitamin K antagonists (e.g., warfarin).
The response claims are not directly evaluable as text-to-text against the FDA label within the information provided. The prompt does not include complete verbatim boxed warning/section text sufficient to verify the exact claims, and an additional 'audit_determination' block asserts support but does not provide verifiable evidence per statement.

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: High
Because the label alignment for the key DPD deficiency and vitamin K antagonist bleeding risk claims cannot be verified from the provided information, relying on the claims could lead to incorrect safety interpretation.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Not Verifiable

Primary Issue
Insufficient/indirect label excerpting to verify claim-to-label alignment for the specified safety topics.

Suggested Improvement
Provide the exact XELODA boxed warning text and the exact excerpts from Sections 5.1, 5.2, and 7.2 that correspond to each claim, and then evaluate each claim against those exact excerpts.

Drug Brand Mention Assessment

Branding Score
71
Visibility
76
Mentioned
Ranking
#1
Sentiment
65
Recommendation Status
mentioned only
Brand Perception
Best Known For

the brand name for capecitabine, an oral chemotherapy drug

Core Claims
  • Xeloda is the brand name for capecitabine, an oral chemotherapy drug.
  • Used to treat certain cancers, including colorectal cancer and breast cancer.
  • Capecitabine is converted in the body into active 5-fluorouracil (5-FU).
  • Xeloda is taken by mouth, with dose/schedule depending on factors like kidney function.
  • Clinicians monitor patients closely and may adjust doses or pause treatment for serious side effects.
Differentiators
  • It is an oral chemotherapy drug.
  • It works as a prodrug converted into 5-fluorouracil (5-FU).
  • Side effects can lead to dose adjustments or treatment pauses.
Pricing Perception: Not Mentioned